House Republicans defeated a provision that would have required drugmakers to post list prices in DTC ads. The provision would have allocated $1 million to the FDA via a spending bill to get the ball rolling on President Donald Trump’s idea. (STAT)

Apple has hired hospital executive Osman Akhtar to help run its employee health clinics. Akhtar was previously COO of nonprofit Minnesota health system Fairview Health Services. Apple has added more than 40 staffers to its health team in the past three months, including doctors, nurses, and care navigators. (CNBC)

AstraZeneca has received FDA approval for its blood cancer drug, Lumoxiti. The drug treats hairy cell leukemia, a rare form of the blood cancer, and is another boost for AstraZeneca’s oncology portfolio. Two of its other cancer drugs, Tagrisso for lung cancer and Lynparza for ovarian cancer, were also approved this year. (Endpoints News)

A lawsuit between Amgen and Sandoz could decide whether patents protect Amgen’s Enbrel from biosimilar competition. Enbrel, which treats chronic conditions like rheumatoid arthritis, psoriatic arthritis, and plaque psoriasis, is the latest blockbuster to face new competition from biosimilars. (BioPharma Dive)

Sanofi will continue to restructure despite hitting its cost-reduction target. The company reached its goal of saving $1.75 million a year earlier than expected, but Sanofi is still planning to reduce its global business units from five to four. (Reuters)